✦ LIBER ✦

Oral Spherical Adsorptive Carbon for the Treatment of Intractable Anal Fistulas in Crohn's Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

✍ Scribed by Fukuda, Yoshihiro; Takazoe, Masakazu; Sugita, Akira; Kosaka, Tadashi; Kinjo, Fukunori; Otani, Yoshimasa; Fujii, Hisao; Koganei, Kazutaka; Makiyama, Kazuya; Nakamura, Toshio; Suda, Takeyasu; Yamamoto, Shojiro; Ashida, Toshifumi; Majima, Akira; Morita, Norikazu; Murakami, Kazunari; Oshitani, Nobuhide; Takahama, Kazuya; Tochihara, Masahiro; Tsujikawa, Tomoyuki; Watanabe, Makoto

Book ID: 120201697
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 431 KB
Category: Article
ISSN: 0002-9270
DOI: 10.1111/j.1572-0241.2008.01860.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tacrolimus for the treatment of fistulas

Tacrolimus for the treatment of fistulas in patients with crohn’s disease: a randomized, placebo-controlled trial

✍ William J Sandborn; Daniel H Present; Kim L Isaacs; Douglas C Wolf; Eugene Green 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Prevention of relapse by mesalazine (Pen

Prevention of relapse by mesalazine (Pentasa®) in pediatric Crohn's disease: A multicenter, double-blind, randomized, placebo-controlled trial

✍ J.-P. Cezard; A. Munck; O. Mouterde; A. Morali; C. Lenaerts; A. Lachaux; D. Turc 📂 Article 📅 2009 🏛 Masson Editeur 🌐 French ⚖ 961 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of lenalidomide in the treatment of moderately severe active Crohn’s disease

✍ J. C. MANSFIELD; M. PARKES; A. B. HAWTHORNE; A. FORBES; C. S. J. PROBERT; R.C. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

Randomized, double-blind, placebo-contro

Randomized, double-blind, placebo-controlled trial of the oral interleukin-12/23 inhibitor apilimod mesylate for treatment of active Crohn's disease

✍ Bruce E. Sands; Eric W. Jacobson; Thomas Sylwestrowicz; Ziad Younes; Gerald Dryd 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 349 KB 👁 1 views

## Background: Interleukin-12 (il-12) and interleukin-23 (il-23) are inflammatory cytokines linked to the th-1 and th-17 phenotypes associated with crohn's disease (cd). we investigated the activity and safety of apilimod mesylate (formerly sta-5326), an oral il-12 and il-23 inhibitor, in patients

Oral pentasa in the treatment of active

Oral pentasa in the treatment of active Crohn?s disease: A meta-analysis of double-blind, placebo-controlled trials

✍ HANAUER, S 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Ciprofloxacin or metronidazole for the t

Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study

✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with